£295 / $515 / €370
Fresenius SE is an international healthcare group providing products and services for dialysis, hospitals and the medical care of patients at home. In addition, Fresenius focuses on hospital operation, as well as on engineering and services for hospitals and other healthcare facilities.
The group comprises the business segments Fresenius Medical Care (FMC), Fresenius Kabi, Fresenius Helios and Fresenius Vamed, all of which are legally-independent entities managed by the operating parent company Fresenius SE. This group structure has been in place since 1st January 2008. Prior to this date, Fresenius Helios and Fresenius Vamed formed a single business segment called Fresenius ProServe.
The Fresenius Medical Device Company Report provides a full review of the company's medical device activities, from its origins to its latest corporate activity, including mergers and acquisitions, agreements, divestitures and litigation. Sections are also included on products, corporate strategy and R&D.
Whatever your interest or involvement, evaluating the performance, success, failures and developments of medical companies is critical. Espicom’s Medical Device Company Reports have been regularly published for over 20 years, and these critically acclaimed and respected management reports provide a complete review of leading players in the field.
Research and Development
Manufacturing and Distribution
Mergers and Acquisitions
Key Corporate Events
The report was produced as part of Medical Device Companies Analysis (MDCA). For more information on MDCA, click here.